Literature DB >> 26642377

Important Hydrogen Bond Networks in Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Design Revealed by Crystal Structures of Imidazoleisoindole Derivatives with IDO1.

Yi-Hui Peng1, Shau-Hua Ueng1, Chen-Tso Tseng1, Ming-Shiu Hung1, Jen-Shin Song1, Jian-Sung Wu1, Fang-Yu Liao1, Yu-Shiou Fan1, Mine-Hsine Wu1, Wen-Chi Hsiao1, Ching-Cheng Hsueh1, Shu-Yu Lin1, Chia-Yi Cheng1, Chih-Hsiang Tu1, Lung-Chun Lee1, Ming-Fu Cheng1, Kak-Shan Shia1, Chuan Shih1, Su-Ying Wu1.   

Abstract

Indoleamine 2,3-dioxygenase 1 (IDO1), promoting immune escape of tumors, is a therapeutic target for the cancer immunotherapy. A number of IDO1 inhibitors have been identified, but only limited structural biology studies of IDO1 inhibitors are available to provide insights on the binding mechanism of IDO1. In this study, we present the structure of IDO1 in complex with 24, a NLG919 analogue with potent activity. The complex structure revealed the imidazole nitrogen atom of 24 to coordinate with the heme iron, and the imidazoleisoindole core situated in pocket A with the 1-cyclohexylethanol moiety extended to pocket B to interact with the surrounding residues. Most interestingly, 24 formed an extensive hydrogen bond network with IDO1, which is a distinct feature of IDO1/24 complex structure and is not observed in the other IDO1 complex structures. Further structure-activity relationship, UV spectra, and structural biology studies of several analogues of 24 demonstrated that extensive hydrophobic interactions and the unique hydrogen bonding network contribute to the great potency of imidazoleisoindole derivatives. These results are expected to facilitate the structure-based drug design of new IDO inhibitors.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26642377     DOI: 10.1021/acs.jmedchem.5b01390

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  36 in total

1.  Discovery of Imidazoisoindole Derivatives as Highly Potent and Orally Active Indoleamine-2,3-dioxygenase Inhibitors.

Authors:  Wangyang Tu; Fanglong Yang; Guoji Xu; Jiangtao Chi; Zhiwei Liu; Wei Peng; Bing Hu; Lei Zhang; Hong Wan; Nan Yu; Fangfang Jin; Qiyue Hu; Lianshan Zhang; Feng He; Weikang Tao
Journal:  ACS Med Chem Lett       Date:  2019-06-03       Impact factor: 4.345

2.  Discovery of indoleamine 2,3-dioxygenase inhibitors using machine learning based virtual screening.

Authors:  Hongao Zhang; Wei Liu; Zhihong Liu; Yingchen Ju; Mengyang Xu; Yue Zhang; Xinyu Wu; Qiong Gu; Zhong Wang; Jun Xu
Journal:  Medchemcomm       Date:  2018-03-01       Impact factor: 3.597

Review 3.  Targeting Metalloenzymes for Therapeutic Intervention.

Authors:  Allie Y Chen; Rebecca N Adamek; Benjamin L Dick; Cy V Credille; Christine N Morrison; Seth M Cohen
Journal:  Chem Rev       Date:  2018-09-07       Impact factor: 60.622

4.  Conformational Plasticity in Human Heme-Based Dioxygenases.

Authors:  Khoa N Pham; Ariel Lewis-Ballester; Syun-Ru Yeh
Journal:  J Am Chem Soc       Date:  2020-12-29       Impact factor: 15.419

Review 5.  Recent advances in the discovery of indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors.

Authors:  Xiu-Xiu Wang; Si-Yu Sun; Qing-Qing Dong; Xiao-Xiang Wu; Wei Tang; Ya-Qun Xing
Journal:  Medchemcomm       Date:  2019-08-15       Impact factor: 3.597

6.  Structural Basis of Inhibitor Selectivity in Human Indoleamine 2,3-Dioxygenase 1 and Tryptophan Dioxygenase.

Authors:  Khoa N Pham; Ariel Lewis-Ballester; Syun-Ru Yeh
Journal:  J Am Chem Soc       Date:  2019-11-14       Impact factor: 15.419

7.  Identification of Potent Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors Based on a Phenylimidazole Scaffold.

Authors:  Michael G Brant; Jake Goodwin-Tindall; Kurt R Stover; Paul M Stafford; Fan Wu; Autumn R Meek; Paolo Schiavini; Stephanie Wohnig; Donald F Weaver
Journal:  ACS Med Chem Lett       Date:  2018-01-11       Impact factor: 4.345

8.  Mapping the Binding Trajectory of a Suicide Inhibitor in Human Indoleamine 2,3-Dioxygenase 1.

Authors:  Khoa N Pham; Syun-Ru Yeh
Journal:  J Am Chem Soc       Date:  2018-10-24       Impact factor: 15.419

Review 9.  Discovery of IDO1 Inhibitors: From Bench to Bedside.

Authors:  George C Prendergast; William P Malachowski; James B DuHadaway; Alexander J Muller
Journal:  Cancer Res       Date:  2017-12-15       Impact factor: 12.701

10.  Structural Study of a Flexible Active Site Loop in Human Indoleamine 2,3-Dioxygenase and Its Functional Implications.

Authors:  Lucía Álvarez; Ariel Lewis-Ballester; Adrián Roitberg; Darío A Estrin; Syun-Ru Yeh; Marcelo A Marti; Luciana Capece
Journal:  Biochemistry       Date:  2016-05-06       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.